Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
November 09 2020 - 5:56AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF
FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the Month of November 2020
Commission File Number: 001-39328
Genetron Holdings Limited
(Exact Name of Registrant as Specified in Its Charter)
1-2/F, Building 11, Zone 1
No.8 Life Science Parkway
Changping District, Beijing, 102206
Peoples Republic of China
+86 10 5090-7500
(Address
of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒
Form 40-F ☐
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
|
|
Genetron Holdings Limited
|
|
|
By:
|
|
/s/ Sizhen Wang
|
Name: Sizhen Wang
|
Title: Director and Chief Executive Officer
|
Date: November 9, 2020
EXHIBIT INDEX
|
|
|
Exhibit
|
|
Description
|
|
|
99.1
|
|
Press Release titled Genetron Health Reports Third Quarter 2020 Unaudited Financial Results and Provides Business Update
|
Genetron (NASDAQ:GTH)
Historical Stock Chart
From Apr 2024 to May 2024
Genetron (NASDAQ:GTH)
Historical Stock Chart
From May 2023 to May 2024